1. Ackerman, S. J., Loegering, D. A., and Gleich, G. J., 1980, The human eosinophil Charcot-Leyden crystal protein: Biochemical characteristics and measurement by radioimmunoassay, J. Immunol. 125: 2118–2126.
2. Ackerman, S. J., Durack, D. T., and Gleich, G. J., 1982a, Eosinophil effector mechanisms in health and disease, in Advances in Host Defense Mechanisms, Vol. 1 ( J. I. Gallin and A. S. Fauci, eds.), pp. 269–293, Raven Press, New York.
3. Ackerman, S. J., Weil, G. J., and Gleich, G. J., 1982b, Formation of Charcot-Leyden crystals by human basophils, J. Exp. Med. 155: 1597–1609.
4. Ackerman, S. J., Kephart, G. M., Habermann, T. M., Greipp, P. R., and Gleich, G. J., 1983a, Localization of eosinophil granule major basic protein in human basophils, J. Exp. Med. 158: 946–961.
5. Ackerman, S. J., Loegering, D. A., Venge, P., Olsson, I., Harley, J. B., Fauci, A. S., and Gleich, G. J., 1983b, Distinctive cationic proteins of the human eosinophil granule: Major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin, J. Immunol. 131: 2977–2982.